NDC 66215-915 – Uptravi
Selexipag 150 ug/1 · Tablet, Film Coated · Oral
Product NDC66215-915
Product details
- Brand name
- Uptravi
- Generic name
- Selexipag
- Labeler
- Actelion Pharmaceuticals US, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA207947
- Marketed since
- May 23, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Prostacyclin Receptor Agonist
Active ingredients
- Selexipag 150 ug/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 66215-915-14 | 1 BOTTLE in 1 CARTON (66215-915-14) / 140 TABLET, FILM COATED in 1 BOTTLE | May 23, 2026 |
Other Uptravi products
- 66215-910 Selexipag 100 ug/1 · Tablet, Film Coated · Actelion Pharmaceuticals US, Inc.
- 66215-602 Selexipag 200 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-604 Selexipag 400 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-606 Selexipag 600 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-608 Selexipag 800 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-610 Selexipag 1000 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-612 Selexipag 1200 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-614 Selexipag 1400 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-616 Selexipag 1600 ug/1 · Tablet, Coated · Actelion Pharmaceuticals US, Inc.
- 66215-718 Selexipag 1800 ug/10mL · Injection, Powder, For Solution · Actelion Pharmaceuticals US, Inc.
- 46014-6040 Selexipag .4 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-6060 Selexipag .6 mg/1 · Capsule · Excella GmbH & Co. KG